Jaffetilchin Investment Partners, LLC Bristol Myers Squibb CO Transaction History

Jaffetilchin Investment Partners, LLC

  • $1.35 Billion
  • Q1 2025

A detailed history of Jaffetilchin Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 12,148 shares of BMY stock, worth $569,133. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,148
Previous 12,439 2.34%
Holding current value
$569,133
Previous $703,000 5.26%
% of portfolio
0.05%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 24, 2025
SELL
$53.9 - $63.11 $15,684 - $18,365
-291 Reduced 2.34%
12,148 $740,000
Q4 2024

Feb 13, 2025
BUY
$51.92 - $59.94 $110,641 - $127,732
2,131 Added 20.67%
12,439 $703,000
Q3 2024

Nov 04, 2024
BUY
$39.66 - $51.75 $15,586 - $20,337
393 Added 3.96%
10,308 $533,000
Q2 2024

Jul 30, 2024
SELL
$40.25 - $52.99 $14,087 - $18,546
-350 Reduced 3.41%
9,915 $411,000
Q1 2024

May 16, 2024
BUY
$47.98 - $54.4 $43,757 - $49,612
912 Added 9.75%
10,265 $556,000
Q4 2023

Feb 13, 2024
SELL
$48.48 - $57.85 $404,808 - $483,047
-8,350 Reduced 47.17%
9,353 $479,000
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $151,035 - $168,880
-2,609 Reduced 12.84%
17,703 $1.03 Million
Q2 2023

Aug 15, 2023
BUY
$63.71 - $70.74 $24,464 - $27,164
384 Added 1.93%
20,312 $1.3 Million
Q1 2023

May 11, 2023
BUY
$65.71 - $74.53 $47,048 - $53,363
716 Added 3.73%
19,928 $1.38 Million
Q4 2022

Feb 10, 2023
SELL
$68.48 - $81.09 $28,830 - $34,138
-421 Reduced 2.14%
19,212 $1.38 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $222 - $131,242
1,708 Added 9.53%
19,633 $1.4 Million
Q2 2022

Aug 15, 2022
SELL
$72.62 - $79.98 $14,306 - $15,756
-197 Reduced 1.09%
17,925 $1.38 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $74,882 - $89,790
1,218 Added 7.21%
18,122 $1.38 Million
Q4 2021

Feb 17, 2022
SELL
$53.63 - $62.52 $123,992 - $144,546
-2,312 Reduced 12.03%
16,904 $1.05 Million
Q3 2021

Oct 25, 2021
BUY
$59.17 - $69.31 $60,708 - $71,112
1,026 Added 5.64%
19,216 $1.14 Million
Q2 2021

Aug 09, 2021
BUY
$61.91 - $67.42 $382,789 - $416,857
6,183 Added 51.49%
18,190 $1.22 Million
Q1 2021

May 10, 2021
BUY
$59.34 - $66.74 $712,495 - $801,347
12,007 New
12,007 $758,000
Q2 2019

Aug 13, 2019
SELL
$44.62 - $49.34 $190,259 - $210,385
-4,264 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$45.12 - $53.8 $2,616 - $3,120
58 Added 1.38%
4,264 $203,000
Q4 2018

Feb 11, 2019
BUY
$48.76 - $63.23 $3,413 - $4,426
70 Added 1.69%
4,206 $219,000
Q3 2018

Oct 05, 2018
BUY
$55.19 - $62.25 $228,265 - $257,466
4,136 New
4,136 $257,000

Others Institutions Holding BMY

# of Institutions
2,806
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email